A Science and Technology Blog
Information shared by the three stakeholders — NEJM, NIAID and Gilead — on critical issues about whether the drug’s ability to reduce mortality is statistically significant and which category of…
A phase-1 trial using a single dose of a vaccine (Ad5-nCoV) that uses a recombinant adenovirus type-5 vector that carries the genetic material that codes for spike glycoprotein of novel…
Six rhesus macaque monkeys were resistant to reinfection following exposure to novel coronavirus. Compared with nose, the lungs had very less virus when challenged. In another study, the researchers tested…
The Recovery Trial will test five already approved drugs — HIV drug Lopinavir-Ritonavir, anti-inflammatory corticosteroid (dexamethasone), anti-malaria drug hydroxychloroquine and antibiotic azithromycin — on COVID-19 patients. It will also test…
Chinese researchers were able to isolate and culture novel coronavirus from faeces samples. Confirmation of infectious virus in faeces samples raises the potential for faecal-oral or faecal-respiratory transmission. During 2002…
Interim results of Moderna’s phase-1 human clinical trial of novel coronavirus vaccine (mRNA-1273) shows the vaccine is safe. The vaccine was also able to elicit neutralizing antibodies. Interim results of…
On May 15, 106 days after the first novel coronavirus case was reported on January 30, with over 85,500 cases, India surpassed China’s tally of 84,038 despite being under a…
In new guidelines issued on May 6, WHO has backed human challenge studies for COVID-19 vaccines on the ground that it could both accelerate vaccine development and make the final…
